Express Scripts (ESRX) Upgraded by Sanford C. Bernstein to Market Perform
Express Scripts (NASDAQ:ESRX) was upgraded by stock analysts at Sanford C. Bernstein from an “underperform” rating to a “market perform” rating in a report issued on Wednesday, The Fly reports.
Other analysts also recently issued research reports about the company. TheStreet raised Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday. Zacks Investment Research raised Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research note on Monday, October 16th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. Jefferies Group set a $72.00 price objective on Express Scripts and gave the stock a “buy” rating in a research note on Tuesday, August 29th. Finally, Deutsche Bank initiated coverage on Express Scripts in a research note on Monday. They issued a “buy” rating and a $75.00 price objective on the stock. Six equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $70.67.
Shares of Express Scripts (NASDAQ:ESRX) opened at $67.84 on Wednesday. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts has a 12 month low of $55.80 and a 12 month high of $77.25. The stock has a market capitalization of $38,603.98, a P/E ratio of 9.96, a price-to-earnings-growth ratio of 1.01 and a beta of 0.88.
In other Express Scripts news, CEO Timothy C. Wentworth acquired 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 31st. The stock was bought at an average price of $61.13 per share, for a total transaction of $489,040.00. Following the acquisition, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Phyllis S. Anderson sold 578 shares of the business’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $63.13, for a total value of $36,489.14. Following the transaction, the vice president now owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,121 shares of company stock valued at $325,920. 0.68% of the stock is owned by company insiders.
Hedge funds have recently modified their holdings of the business. Harel Insurance Investments & Financial Services Ltd. increased its position in Express Scripts by 20.9% during the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,503 shares of the company’s stock valued at $114,000 after buying an additional 260 shares in the last quarter. Burt Wealth Advisors increased its position in Express Scripts by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after buying an additional 174 shares in the last quarter. Independent Advisor Alliance acquired a new position in Express Scripts during the 4th quarter valued at about $124,000. Dubuque Bank & Trust Co. increased its position in Express Scripts by 53.1% during the 1st quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock valued at $116,000 after buying an additional 608 shares in the last quarter. Finally, Capital Analysts LLC increased its position in Express Scripts by 15.2% during the 4th quarter. Capital Analysts LLC now owns 1,777 shares of the company’s stock valued at $122,000 after buying an additional 235 shares in the last quarter. Institutional investors and hedge funds own 88.44% of the company’s stock.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.